April 10th 2025
Study participants treated with elinzanetant experienced significantly reduced hot flash frequency vs paroxetine, desvenlafaxine, and gabapentin in a new meta-analysis.
Stakeholders Discuss Gaps in Women's Healthcare Across the Lifespan